Neuroepidemiology involves the study of chronic and acute neurological disorders, which are of major importance to clinical medicine, public health, and health care delivery. Neurological diseases are one of the most burdensome health conditions in western countries with a globally increasing prevalence.
The neuroepidemiology research at Department of Clinical Epidemiology helps identify short- and long-term risk factors and prognostic factors for diseases of the nervous system. The particular aim of the projects is to study the impact of acute and chronic conditions, medication use, and social risk factors on prognosis of neurological disorders. Together with our collaborators at Stanford University and University of California, San Francisco, we examine dementia and dementia subtypes, Alzheimer’s disease, vascular dementia, and other dementia. Identifying risk factors to prevent or delay dementia onset will have a major public health impact.
A deeper understanding of the association between stress disorders/depression and dementia could have a significant public health impact. Therefore, DCE is collaborating with researchers from Boston University on studies analyzing the risk of all-cause dementia and dementia subtypes in patients with stress disorders/depression.
We are one of 26 partners in the European public-private partnership Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi‐modal data Access Platform (ROADMAP).
The project provides the foundation for an integrated data environment and framework for real-world evidence.